The Ewha Medical Journal
Ewha Womans University College of Medicine and Ewha Medical Research Institute
Guidelines

Clinical practice guidelines for the diagnosis and treatment of scabies in Korea: Part 1. Epidemiology, clinical manifestations, and diagnosis — a secondary publication

Jin Park1https://orcid.org/0000-0002-8830-5479, Soon-Hyo Kwon2https://orcid.org/0000-0002-7295-5725, Young Bok Lee3https://orcid.org/0000-0002-8642-2479, Hei Sung Kim4https://orcid.org/0000-0003-0576-0474, Jie Hyun Jeon5https://orcid.org/0000-0003-2456-7573, Gwang Seong Choi6,*https://orcid.org/0000-0002-5766-0179
1Department of Dermatology, Jeonbuk National University Medical School, Jeonju, Korea
2Department of Dermatology, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea
3Department of Dermatology, Uijeongbu St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea
4Department of Dermatology, Incheon St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea
5Department of Dermatology, Korea University Guro Hospital, Seoul, Korea
6Department of Dermatology, Inha University Hospital, Incheon, Korea
*Corresponding author: Gwang Seong Choi, Department of Dermatology, Inha University Hospital, 27 Inhangro, Jung-gu, Incheon 22332, Korea, E-mail: garden@inha.ac.kr

*This is a secondary publication of Park J, Kwon SH, Lee YB, Kim HS, Jeon JH, Choi GS. Clinical Practice Guidelines for the Diagnosis and Treatment of Scabies in Korea: Part 1. Epidemiology, Clinical Manifestations, and Diagnosis. Korean J Dermatol 2023;61(7):393-403 under the permission of the editor of the Korean Journal of Dermatology after English translation.

© Copyright 2024 Ewha Womans University College of Medicine and Ewha Medical Research Institute. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Oct 13, 2024; Accepted: Oct 13, 2024

Published Online: Oct 31, 2024

Abstract

Scabies is a skin disease caused by the parasite Sarcoptes scabiei var. hominis, which is primarily transmitted via direct skin or sexual contact or, less commonly, via contact with infested fomites. In Korea, the incidence of scabies has decreased from approximately 50,000 cases per year in 2010 to about 30,000 cases per year in 2021. However, outbreaks are consistently observed in residential facilities, such as nursing homes, especially among older adults. The clinical manifestations of scabies vary based on the patient’s age, health status, the number of mites, and the route of transmission. Typical symptoms of classic scabies include intense nocturnal itching and characteristic skin rashes (burrows and erythematous papules), with a predilection for the interdigital web spaces, inner wrists, periumbilical areas, axillae, and genital areas. In contrast, older adults with immunodeficiency or neurological disorders may exhibit hyperkeratotic scaly lesions or an atypical distribution with mild to no itching (crusted scabies). The diagnosis of scabies is based on clinical symptoms and the results of diagnostic tests aimed at identifying the presence of the parasite. While a history of close contact and characteristic clinical findings suggest scabies, confirmation of the diagnosis requires detecting scabies mites, eggs, or scybala. This can be achieved through light microscopy of skin samples, non-invasive dermoscopy, and other high-resolution in vivo imaging techniques.

Keywords: Diagnosis; Epidemiology; Practice guideline; Sarcoptes scabiei; Scabies

Introduction

Background

Scabies is a highly contagious skin disease marked by severe itching, resulting from the infestation of mites within the skin. As of 2017, over 200 million people globally were affected, with a notably high prevalence in tropical and low-income areas [1]. In Korea, scabies was once prevalent, representing about 10% of outpatient visits in some general hospitals until the early 1980s. However, the incidence declined to less than 1% by the 1990s, likely due to strengthened public health measures. Recent years have seen a resurgence of scabies, which is thought to be linked to the increase in long-term care facilities associated with an aging population. In 2010, data from the Health Insurance Review and Assessment Service reported over 50,000 cases, but this number decreased to around 30,000 cases by 2021. Despite this decline, there remains a risk of scabies re-emerging.

To reduce scabies outbreaks, especially in communal living settings like nursing homes, it is crucial to implement preventive measures, ensure early detection, and adopt effective management practices. These steps help mitigate risk factors and curb the spread of the disease. Several countries, including the U.S. and various European nations, have established guidelines for the diagnosis, treatment, and prevention of scabies [24]. In Korea, the Korea Disease Control and Prevention Agency (KDCA) has been issuing guidance on scabies prevention and management since 2018 [5,6]. Nevertheless, clinical guidelines developed by dermatology experts with experience in treating scabies are vital to broadly support healthcare providers.

Objectives

In 2023, the Korean Dermatological Association (KDA) prioritized the eradication of scabies, launching clinical services, educational programs in communal facilities, and public awareness campaigns. To bolster these initiatives, the authors formed a committee within the KDA tasked with developing standardized clinical guidelines for managing scabies. We believe this guideline will serve as a valuable resource for everyone engaged in the treatment and prevention of scabies.

Ethics statement

As this was a literature review study, it did not require approval from an institutional review board. Informed consent was obtained from the patients depicted in the figures for the use of their photographs.

Definition, transmission, and epidemiology

  • - Scabies is a skin infection caused by the scabies mite. It is transmitted primarily through direct skin contact or sexual contact with an infected individual. Transmission can also occur, though less commonly, through indirect contact with contaminated objects.

  • - The number of scabies cases in Korea has steadily declined, from approximately 50,000 in the early 2010s to around 30,000 in 2021. While scabies is more prevalent among older adults and its incidence increases with an aging population, about 17% of cases also occur in individuals under the age of 20.

  • - Factors contributing to the ongoing occurrence of scabies cases include the expansion of elderly care facilities, increasing drug resistance, diagnostic difficulties due to atypical clinical presentations in clean environments or cases of scabies incognito, and a rise in travel from regions where the disease is endemic.

Definition

Scabies is a skin infection caused by the mite Sarcoptes scabiei, which belongs to the phylum Arthropoda, subclass Arachnida, order Astigmata, and family Sarcoptidae [7]. This mite parasitizes more than 40 animal species, burrowing into the skin and causing infections in both humans and animals. There are different varieties of scabies mites that infect humans and other animals. In Korea, three types have been identified: S. scabiei var. hominis (human scabies mite), S. scabiei var. canis (dog scabies mite), and S. scabiei var. suis (pig scabies mite). Of these, only S. scabiei var. hominis is transmitted between humans and causes clinical disease, and is commonly referred to as the "scabies mite" in medical practice. Mature female mites measure 0.30–0.45 mm in length and 0.25–0.35 mm in width, while mature male mites are approximately half that size [5]. They are oval and grayish-white, with brown legs and a gnathosoma (mouth parts) that is distinct from the idiosoma (body), which is short, blunt, and round with eight legs. These mites lack eyes and respiratory organs, and feature a distinctive long bristle on the third pair of legs.

The lifecycle of S. scabiei comprises four stages: egg, larva, nymph, and adult [5]. After mating on the skin surface, female mites burrow 1–2 mm into the stratum corneum. Here, they lay an average of 35–50 eggs throughout their 4–6-week lifespan. In contrast, male mites typically die within two days of mating. The eggs hatch into larvae within 4–5 days, develop into nymphs, and reach adulthood within 10–14 days. Scabies mites move at a rate of approximately 2.5 cm per minute on the skin and can survive for 24–36 hours, and up to one week, off the host. They are most active at temperatures above 20°C.

Transmission

Scabies primarily spreads through direct skin-to-skin or sexual contact with an infected person. It can also spread less commonly through indirect contact with contaminated items such as fabrics, doorknobs, bedding, or furniture. Individuals infected with scabies can transmit the disease during the asymptomatic incubation period and remain contagious until the mites and eggs are eliminated through treatment. Crusted scabies, which is highly contagious, often occurs in communal settings such as nursing homes, long-term care facilities, prisons, and daycare centers. High-risk groups for scabies infection include household members and sexual partners of individuals with scabies. Crusted scabies is more likely to affect those who are immunocompromised, older adults, individuals with physical or mental disabilities, and those in poor conditions or with severe underlying diseases [6].

Epidemiology

In Korea, the prevalence of scabies among outpatients at eight general hospitals across six regions, including Seoul, was approximately 2% in the 1960s, rising to 3%–7% in the 1970s, and reaching 10% in the early 1980s. However, by the 1990s, it had declined to below 1% [8]. Data from the Korean Health Insurance Review and Assessment Service show that the number of scabies cases in Korea decreased from 51,331 in 2010 to 29,693 in 2021 (Fig. 1) [9]. During the same period, the age-standardized incidence rate per 100,000 people fell from 97.6 to 43.4. Factors contributing to this decline include improved personal hygiene, heightened awareness of scabies in institutional settings such as nursing facilities, and the social isolation measures and movement restrictions associated with the COVID-19 pandemic.

emj-47-4-72-g1
Fig. 1. Epidemiology of scabies in Korea, 2010–2021. (A) Incidence rate. (B) Age-standardized incidence rate. (C) Age distribution of patients.
Download Original Figure

Scabies was most prevalent among individuals in their 40s, accounting for 16% of cases in 2010–2011. However, from 2012 to 2020, the highest incidence shifted to those in their 50s, with a steady increase in this age group. The higher incidence among older adults can be attributed to factors such as population aging, an increase in long-term care facilities, and relative poverty among older adults [9]. In contrast, among individuals under 20, the rate of scabies declined from 33.5% of all cases in 2010 to 16.9% in 2021. The rise in scabies cases among older adults suggests that infections in younger individuals are likely due to secondary transmission from caregivers, healthcare workers, or family members.

The persistent incidence of scabies can be attributed to several factors, including the expansion of elderly care facilities, increasing drug resistance, challenges in diagnosing atypical or cryptic scabies in clean environments, and increased travel to endemic regions [5,10]. Additionally, the rising trend of group infections in facilities, driven by an aging population and prolonged stays, has emerged as a significant social concern.

Clinical manifestations

  • - The clinical presentation of scabies varies depending on the patient's age, health status, mite load, and route of transmission.

  • - Characteristic skin symptoms of the condition include intense itching that worsens at night, along with the presence of burrows and red bumps in typical areas. These areas often include the interdigital web spaces of the fingers, the inner wrists, and around the navel.

  • - In older adults, immunocompromised persons, or infants, scabies may manifest differently, exhibiting less itching and atypical skin features. These can include involvement of the scalp, face, palms, and soles, as well as hyperkeratotic scaling or nodules.

The clinical manifestations of scabies vary based on factors such as the patient's age, health status, underlying diseases, the number of mites present, the route of transmission, and the time elapsed before diagnosis. While nocturnal itching and the appearance of burrows are common symptoms, infants and older patients with underlying conditions may present with unique and varied symptoms. Many patients experience severe itching that disrupts sleep and diminishes their quality of life [11]. Additionally, they may develop skin complications such as bacterial infections, eczema, or bullous pemphigoid [12]. In rare cases, systemic complications such as glomerulonephritis, vasculitis, lymphadenopathy, and sepsis may arise [13]. Scabies is typically categorized into three types based on its clinical features: classic, crusted, and nodular (Table 1).

Table 1. Clinical characteristics of scabies
Classic scabies Crusted scabies Nodular scabies
Prevalence Common Rare Uncommon (10%–30%)
Infectivity Small number of mature mites per patient (five or fewer in mature female mites in half of the cases) Large numbers of mature mites per patient (1–2 million; infectivity: very high) Similar to classic scabies
Route of transmission Direct skin contact Direct skin contact Direct skin contact
High-risk groups Immunocompetent individuals (more common in older adults) Immunocompromised individuals (e.g., AIDS, malignant tumor, autoimmune disease, immunosuppressant or steroid use, Down syndrome, neurologic or psychological disorders) Sexually active individuals
Infants and younger children
Pruritus Intense (worse at night) Mild or absent Intense
Typical skin rash presentation Multiple burrows, or erythematous macules and papules (2–3 mm) (often excoriated) Hyperkeratotic, fissured, scaly erythematous patch or plaque (reminiscent of psoriasis or seborrheic dermatitis) Multiple red-brown nodules (5–20 mm)
Burrows
Typical skin rash distribution Common: fingers (interdigital web spaces), inner wrists, extensor aspects of the extremities (elbows and knees), periumbilical area, axillary folds, waist, buttocks, and genital area
Head, palms, and soles in infants and young children
Bony prominences (fingers, elbows, and iliac crest), palms and soles, head (face and scalp), auricular region Genital area (penis and scrotum in men), buttock, inguinal, and axillary regions
Complications Secondary eczema or bacterial infection, glomerulonephritis Erythroderma, lymphadenopathy, sepsis

AIDS, acquired immune deficiency syndrome.

Download Excel Table
Classic scabies

The primary symptom of classic scabies is intense itching that worsens at night. An analysis of Korean scabies patients revealed that 76.4% experienced nocturnal itching, 23.6% reported severe itching, and 13.8% had sleep disturbances due to the intense itching. This itching is caused by the direct activity of the mites as well as an immunological reaction, primarily Type IV delayed hypersensitivity, to their digestive secretions, excretions, and eggs [14,15]. The worsening of symptoms at night is linked to increased mite activity, elevated secretion levels, and heightened nerve sensitivity, which occurs due to a decrease in sympathetic nervous activity [14].

The incubation period before the onset of itching typically ranges from 4 to 6 weeks. However, it can be shorter (i.e., less than 4 weeks) when a large number of scabies mites are present [16]. In cases of reinfection, symptoms can manifest within 1 to 3 days [17]. Itching may continue for several weeks even after the mites have been eradicated. The severity of the itching often correlates with the number of scabies lesions.

The burrows created by female mites as they tunnel through the stratum corneum are distinctive dermatological manifestations. These burrows typically measure 2–10 mm in length and appear as grayish-white or light brown linear tracks, either thread-like or wavy. Upon close examination, one might notice fine scales on their surface, accompanied by slightly darker or raised edges and ends (Fig. 2A, B) [3]. Commonly, these burrows are located between the interdigital web spaces of the fingers, on the inner wrists, around the navel, buttocks, male genitalia, female breasts, and armpits [2,4]. This distribution pattern indicates the mites' preference for warmer, thinner, and less hairy skin [18]. In approximately 80% of patients, 1 to 4 burrows are found within the same area of skin. Small, erythematous macules and papules, typically 2–3 mm in size and often accompanied by severe itching, are common skin lesions resulting from hypersensitivity to mites (Fig. 2C, D). These lesions are usually observed around the lower abdomen, inner thighs, axillae, and inner arms, although they do not always correspond with the distribution of the burrows [2,17]. In most healthy adults, the scalp, face, palms, and soles are typically unaffected. However, in infants and older adults, one may observe burrows, papules, vesicles, and pustules on the palms and soles [19]. In cases of prolonged infestation, repeated scratching and infection can result in atypical presentations, including excoriations, oozing, and crusted lesions (Fig. 2E, F).

emj-47-4-72-g2
Fig. 2. Clinical photographs of scabies. (A,B) Characteristic classic scabies showing burrows in the interdigital web space. (C,D) Typical erythematous macules, papules, and excoriated crusts in the typical distribution (axilla, groin) of classic scabies. (E,F) Atypical clinical features of scabies in infants showing palmoplantar involvement or atypical skin lesions, such as wheals or vesicles. (G) Crusted scabies revealing diffuse hyperkeratotic scaly lesions in immunocompromised individuals. (H) Nodular scabies revealing multiple nodules in the scrotum.
Download Original Figure
Crusted scabies

Previously known as Norwegian scabies, crusted scabies primarily affects immunocompromised individuals due to physical or mental disabilities, chronic systemic illnesses, or prolonged steroid use [20]. However, approximately 40% of cases do not have identifiable risk factors [21]. This form of scabies is highly contagious because of the large number of mites present, yet patients typically experience minimal or no itching due to a diminished cellular immune response. It is characterized by extensive, thick hyperkeratotic scales and fissures, which resemble psoriasis or chronic eczema (Fig. 2G). Skin lesions commonly appear on the palms, soles, head, neck, buttocks, elbows, and knees, particularly in areas subjected to friction. Burrows may also be present in non-hyperkeratotic areas. In some instances, the infection can extend to the nails, causing nail deformities, or progress to erythroderma [2224]. Secondary bacterial infections and lymphadenopathy are common, and patients who are immunocompromised are at an increased risk of developing sepsis [25].

Nodular scabies

Nodular scabies is a variant of classic scabies, affecting approximately 10%–30% of all cases. It is characterized by intensely itchy, red-brown papules and nodules ranging from 5–20 mm in size. These lesions are typically located on the male genitalia, buttocks, groin, and axillae (Fig. 2H). In infants, nodules can also be found on the trunk, limbs, or even across the entire body. Early in the disease, burrows may occasionally be visible on the surface of these nodules. Even after the mites have been eradicated, the nodules often persist for some time, with 80% resolving within three months, though some may last up to a year [26].

Uncommon variants of scabies include canine scabies and scabies incognito. Canine scabies is caused by S. scabiei var. canis and is transmitted from dogs or other animals. Due to host specificity, it typically resolves spontaneously in humans within a few days and does not spread between humans [27,28]. Scabies incognito occurs when the prolonged use of steroids or other treatments suppresses the immune and inflammatory responses, leading to atypical clinical features [29,30]. Instead of the usual symptoms of itching or burrows, scabies incognito presents with widespread eczema-like lesions, which can result in a delayed diagnosis and the potential for ongoing transmission to others.

Diagnosis

  • - Scabies is diagnosed clinically through a patient's history of contact with others who have scabies and the presence of characteristic skin symptoms. Confirmation of the diagnosis is achieved by identifying mites using microscopy or dermoscopy.

  • - A clinical diagnosis of scabies is possible when burrows are visible or when there is a history of contact with a scabies patient, accompanied by nodules in the genital area or characteristic small papules in typical locations.

  • - Microscopic examination of skin samples provides high specificity. In contrast, dermoscopy is a quick and convenient method that achieves accuracy comparable to microscopy when conducted by experienced clinicians. This technique is particularly advantageous for older patients or infants who may have difficulty cooperating during testing.

The diagnosis of scabies primarily relies on a clinical evaluation, which includes assessing contact history and identifying characteristic skin lesions. Confirmation is achieved through microscopy, dermoscopy, or high-magnification imaging techniques that detect mites [24,31]. In many medical institutions in Korea, there is limited access to these mite detection tests; thus, treatment for scabies often begins based solely on the clinical diagnosis [32]. According to a Korean multicenter study, approximately half of the scabies cases were diagnosed clinically without confirmatory testing. While a patient's history and typical skin findings are invaluable for raising suspicion and aiding in the diagnosis when confirmatory tests are unavailable, they cannot fully replace diagnostic tests. Special consideration should also be given to immunocompromised patients, infants, and older adults, who may not exhibit typical clinical symptoms.

Recently, a consensus was reached by 34 global scabies experts on standardized diagnostic criteria for scabies [2,33]. These criteria categorize the diagnosis into three levels based on diagnostic certainty: suspected, clinical, and confirmed. This stratification provides a valuable tool for diagnosing classic scabies in various clinical settings [34]. The sensitivity and specificity of these standardized criteria range from 69% to 83% and 70% to 96%, respectively [33,34]. However, these criteria may be less appropriate for atypical cases, such as crusted scabies. A simplified version of the criteria, presented in Table 2, is also in use, although its accuracy still requires further validation.

Table 2. Criteria for the diagnosis of scabies1)
Stage Criteria2)
Suspected scabies - Close contact with scabies patients and pruritus
- Close contact with scabies patients and skin rash (any type)
Clinical scabies - Scabies burrows
- Close contact with scabies patients, pruritus, and typical skin lesions (one of the following):
 - Typical erythematous papules or vesicles in a typical distribution (including the periumbilical area, inner thigh, buttock, axilla, and inner forearm)
 - Multiple nodules in the genital area or axilla
 - Multiple papules, vesicles, or pustules in the palmoplantar distribution of an infant
Confirmed scabies - Detection of scabies mites, eggs, or scybala in skin samples using light microscopy
- Visualization of scabies mites, eggs, or scybala using high-resolution imaging techniques, including dermoscopy in vivo

These criteria were modified from the 2020 International Alliance for the Control of Scabies.

At least one item for each stage.

Download Excel Table
Clinical diagnosis

Contact history is a crucial factor in diagnosing scabies, as it is observed in most cases. When a patient presents with pruritic skin lesions and has a history of contact with someone diagnosed with scabies, scabies should be suspected. This contact history can include direct interactions with the infected individual, such as those involving cohabitants, family members, sexual partners, roommates, healthcare providers, or caregivers. Additionally, individuals who have had close skin contact or direct exposure to contaminated clothing or bedding are considered to be at high risk (Table 3) [2,5]. Therefore, it is essential to thoroughly investigate contact history, family history, sexual relationships, and any visits or stays in long-term care facilities during the history-taking process. However, not all patients with scabies will have an identifiable contact history, and in some cases, the contact may not yet have been diagnosed with scabies. Furthermore, even with a known contact history, itching and skin lesions may not manifest until the end of the incubation period.

Table 3. Definition of close contact and high-risk groups for transmission of scabies
Close contact - Skin contact1) with an individual diagnosed with scabies
- Sexual contact with an individual diagnosed with scabies (especially, nodular scabies)
- Brief direct contact with linens (such as towels, clothing, and bedding) used by an individual diagnosed with scabies (especially, crusted scabies)
High-risk groups - Family members, housemates, and sex partners living with an individual diagnosed with scabies
- Healthcare workers, caregivers, and inpatients who share the living environment of an individual diagnosed with scabies (occupational exposures)
- A person who has handled linens (towels, clothing, and bedding) of an individual diagnosed with scabies

At least 5–10 minutes of close and continuous contact for acquiring classic scabies (a simple touch, handshake, and hugs are not generally included, except in crusted scabies).

Download Excel Table

Itching is a common symptom among patients with scabies, though it is nonspecific and alone is not sufficient for diagnosis. This is especially pertinent in older adults, who may experience intense itching as a result of dry skin, medications, or psychological factors. Similarly, immunocompromised individuals or young children might exhibit mild or no itching at all; therefore, the absence of itching should not rule out the possibility of scabies.

Clinically, scabies is often diagnosed through the observation of burrows during a physical examination or when a patient with a history of contact presents with distinctive skin findings, such as nodular lesions on the male genitalia or pruritic papules in typical locations. Burrows, a hallmark of scabies, are commonly located between the interdigital web spaces of the fingers or on the inner wrists. Although these thread-like lesions might be visible to the naked eye of an experienced physician, early stages of the disease, secondary eczema, or bacterial infections can obscure the burrows. Therefore, it is advisable to thoroughly examine typical sites. In infants, it is also important to check the palms, soles, and scalp. The "burrow ink test" can be helpful in identifying burrows. This test involves rubbing the suspected burrow area with a surgical marker and then removing the excess ink with an alcohol swab (Fig. 3) [35,36]. Erythematous papules with intense itching on the lower abdomen, inner thighs, or nodules on the male genitalia can also support the diagnosis, although these findings are not specific.

emj-47-4-72-g3
Fig. 3. Burrow ink test (staining of the linear burrow with washable blue ink). (A) Naked eye examination, (B) hand-held polarized dermoscope (×10), and (C) high-resolution videodermoscope (×100; circle: burrow, arrowhead: scabies mite).
Download Original Figure
Confirmed diagnosis (scabies mite detection)

Scabies can be confirmed by visually detecting live mites through a microscopic examination of skin samples, dermoscopy, or other high-magnification imaging methods [2]. For microscopy, skin samples are collected from suspected burrows using a scalpel or adhesive tape, placed on a slide, and observed under a light microscope (Fig. 4). Applying mineral oil to the lesion before sampling helps to capture live mites, eggs, and feces (scybala) [37]. Alternatively, potassium hydroxide can be used to dissolve the keratin or debris in skin samples, which offers a clearer view of mites and eggs but dissolves mite feces. Although microscopy has high specificity, it can be cumbersome and has low sensitivity, with positive detection rates varying from 10% to 70%, depending on the examiner’s skill and sampling site [38]. Sampling from typical burrows without abrasion of eczema on areas such as the finger webs and inner wrists can improve detection rates. A negative result does not exclude scabies if clinical suspicion remains high. In a Korean study, the scabies mite detection rate from a single burrow is around 36%, and only 66.7% of scabies cases have detectable mites [39].

emj-47-4-72-g4
Fig. 4. Skin scraping method findings of scabies. (A–C) Skin scraping method. Adapted from Cho [7] with CC-BY-NC. (D,E) Microscopic findings from a skin scraping sample showing scabies mites, eggs, and scybala in vitro (×100).
Download Original Figure

Dermoscopy is becoming increasingly popular as a quick, non-invasive, and convenient diagnostic method. While high magnification (×50 or greater) provides the best accuracy, skilled clinicians are able to detect mites using handheld devices at magnifications of ×10–20 [40]. Typically, dermoscopy reveals a distinctive brown triangular mite head, known as the "delta sign" or "hang glider sign," along with a jet-like burrow filled with bubbles and secretions, which gives a "jet with condensation trail" appearance (Fig. 5) [41,42]. These features are recognized for their high sensitivity and specificity [4345]. Additional indicators include the wake sign, which shows the trail of mite movement, and the gray-edge line or bluish-white structures that represent mite feces [46]. Dermoscopy is particularly advantageous for patients who might find sample collection distressing, such as older adults, immunocompromised individuals, and infants, as it spares them from unnecessary skin sample collection. However, the detection rate can vary significantly depending on the examiner's expertise and the specific area being observed. Other high-magnification imaging techniques, such as reflectance confocal microscopy and optical coherence tomography, are also capable of identifying mites within the stratum corneum, though these methods are rarely used in clinical practice [4750].

emj-47-4-72-g5
Fig. 5. Dermoscopic findings of scabies in vivo. (A) A triangular mite (hang glider sign) and curvilinear burrow (jet with condensation trail; ×10). (B) Multiple scabies mites and feces within burrows in crusted scabies (×10). (C) Scabies mite using a high-resolution imaging device (×300).
Download Original Figure

Skin biopsies are generally not performed for diagnosing scabies; however, they can reveal mites, eggs, and feces in the stratum corneum, as well as inflammatory infiltrates, including eosinophils, in the dermis (Fig. 6) [51]. Blood tests do not aid in the diagnosis of scabies. While eosinophils and immunoglobulin E levels may be elevated in patients experiencing itchiness, these elevations are nonspecific. Tests for specific mite antibodies are not commonly used due to their lack of sensitivity and low specificity, which results from cross-reactivity with dust mites [52]. In cases where sexual transmission is suspected or nodules are present in the genital area, testing for sexually transmitted infections, such as syphilis, is advised [53].

emj-47-4-72-g6
Fig. 6. Histopathological findings of scabies showing a burrow in the stratum corneum with Sarcoptes scabiei mites (hematoxylin and eosin stain; ×400 [inset: ×40]).
Download Original Figure

Advanced molecular methods are being developed to detect mites. These include nested PCR, reverse transcription-PCR targeting the cox-1 gene, matrix-assisted laser desorption/ionization-time of flight mass spectrometry, and loop-mediated isothermal amplification. However, further research is required to validate these methods for routine clinical use [47,5456].

Differential diagnosis

Given the nonspecific itching and varied clinical presentations of scabies, it is essential to differentiate it from several other skin conditions (Table 4) [2]. The primary differential diagnoses for classic scabies include insect bites, papular urticaria, atopic dermatitis, contact dermatitis, folliculitis, impetigo, and pityriasis rosea. Delusional parasitosis should be considered in patients who believe in a mite invasion on or inside the skin and repeatedly request diagnostic testing for mite detection without a history of contact. These patients may present objects such as hair, lint, or skin flakes, known as "the matchbox sign," as "proof" of the infestation, despite normal findings on examination. Crusted scabies, characterized by its hyperkeratotic scaling, can closely resemble xerotic eczema, psoriasis, or cutaneous T-cell lymphoma. It may also be mistaken for seborrheic dermatitis when it appears on the head and neck. Nodular scabies may be confused with pseudolymphoma or secondary syphilis, while common lesions on the palms and soles in infants should be differentiated from conditions such as infantile acropustulosis or pompholyx (dyshidrotic eczema).

Table 4. Differential diagnosis of various types of scabies
Type Main differential diagnosis
Classic scabies Arthropod bites, atopic dermatitis, chickenpox, contact dermatitis, delusion of parasitosis, dermatitis herpetiformis, folliculitis, impetigo, Langerhans cell histiocytosis, lichen planus, papular urticaria, pityriasis rosea
Crusted scabies Atopic dermatitis, Darier disease, mycosis fungoides, erythroderma, pityriasis rubra pilaris, psoriasis, seborrheic dermatitis, Sezary syndrome, xerotic eczema
Nodular scabies Prurigo nodularis, pseudolymphoma, secondary syphilis (condyloma lata)
Infantile scabies Infantile acropustulosis, dyshidrotic eczema (pompholyx), urticaria pigmentosa
Download Excel Table

Authors' contributions

Project administration: Park J, Kwon SH, Lee YB, Kim HS, Jeon JH, Choi GS

Conceptualization: Park J, Kwon SH, Lee YB, Kim HS, Jeon JH, Choi GS

Methodology & data curation: Park J, Kwon SH, Lee YB, Kim HS, Jeon JH, Choi GS

Funding acquisition: not applicable

Writing – original draft: Park J, Kwon SH, Lee YB, Kim HS, Jeon JH, Choi GS

Writing – review & editing: Park J, Kwon SH, Lee YB, Kim HS, Jeon JH, Choi GS

Conflict of interest

No potential conflict of interest relevant to this article was reported.

Funding

Not applicable.

Data availability

Not applicable.

Acknowledgments

This study was conducted with the support of the Korean Dermatological Association. We thank the members of the Korean Society for Cutaneous Mycology and Infection for their valuable guidance. All images published in this paper have been used with permission.

Supplementary materials

Not applicable.

References

1.

Zhang W, Zhang Y, Luo L, Huang W, Shen X, Dong X, et al. Trends in prevalence and incidence of scabies from 1990 to 2017: findings from the global burden of disease study 2017. Emerg Microbes Infect 2020; 9(1):813-816

2.

Engelman D, Yoshizumi J, Hay RJ, Osti M, Micali G, Norton S, et al. The 2020 International Alliance for the Control of Scabies Consensus Criteria for the diagnosis of scabies. Br J Dermatol 2020; 183(5):808-820

3.

Executive Committee of Guideline for the Diagnosis and Treatment of Scabies. Guideline for the diagnosis and treatment of scabies in Japan (third edition). J Dermatol 2017; 44(9):991-1014

4.

Salavastru CM, Chosidow O, Boffa MJ, Janier M, Tiplica GS. European guideline for the management of scabies. J Eur Acad Dermatol Venereol 2017; 31(8):1248-1253

5.

Korea Disease Control and Prevention Agency. Guide for prevention and management of scabies and head lice. Cheongju: Korea Disease Control and Prevention Agency. 2018.

6.

Korea Disease Control and Prevention Agency. Guide for prevention and management of scabies in convalescent hospital. Cheongju: Korea Disease Control and Prevention Agency. 2019.

7.

Cho BK. Reemerging skin disease caused by arthropods I: scabies. J Korean Med Assoc 2011; 54(5):511-520

8.

Lee WK, Cho BK. Taxonomical approach to scabies mites of human and animals and their prevalence in Korea. Korean J Parasitol 1995; 33(2):85-94

9.

Kim JH, Cheong HK. Epidemiologic trends and seasonality of scabies in South Korea, 2010-2017. Korean J Parasitol 2019; 57:399-404

10.

Lee SK, Kim JH, Kim MS, Lee UH. Risk factors for scabies treatment resistance: a retrospective cohort study. J Eur Acad Dermatol Venereol 2022; 36(1):126-132

11.

Jannic A, Bernigaud C, Brenaut E, Chosidow O. Scabies itch. Dermatol Clin 2018; 36(3):301-308

12.

Romani L, Steer AC, Whitfeld MJ, Kaldor JM. Prevalence of scabies and impetigo worldwide: a systematic review. Lancet Infect Dis 2015; 15(8):960-967

13.

Chandler DJ, Fuller LC. A review of scabies: an infestation more than skin deep. Dermatology 2019; 235(2):79-90

14.

Kim HS, Hashimoto T, Fischer K, Bernigaud C, Chosidow O, Yosipovitch G. Scabies itch: an update on neuroimmune interactions and novel targets. J Eur Acad Dermatol Venereol 2021; 35(9):1765-1776

15.

Walton SF, Oprescu FI. Immunology of scabies and translational outcomes: identifying the missing links. Curr Opin Infect Dis 2013; 26(2):116-122

16.

Chosidow O. Clinical practice: scabies. N Engl J Med 2006; 354(16):1718-1727

17.

Chosidow O. Scabies and pediculosis. Lancet 2000; 355(9206):819-826

18.

Arlian LG, Morgan MS. A review of Sarcoptes scabiei: past, present and future. Parasit Vectors 2017; 10(1):297

19.

Paller AS. Scabies in infants and small children. Semin Dermatol 1993; 12(1):3-8.

20.

Wong SSY, Woo PCY, Yuen K. Unusual laboratory findings in a case of Norwegian scabies provided a clue to diagnosis. J Clin Microbiol 2005; 43(5):2542-2544

21.

Roberts LJ, Huffam SE, Walton SF, Currie BJ. Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect 2005; 50(5):375-381

22.

Das A, Bar C, Patra A. Norwegian scabies: rare cause of erythroderma. Indian Dermatol Online J 2015; 6(1):52-54

23.

Devi GC, Hazarika N. Erythroderma secondary to crusted scabies. BMJ Case Rep 2021; 14(12):248000

24.

DePaoli RT, Marks VJ. Crusted (Norwegian) scabies: treatment of nail involvement. J Am Acad Dermatol 1987; 17(1):136-139

25.

Lin S, Farber J, Lado L. A case report of crusted scabies with methicillin-resistant Staphylococcus aureus bacteremia. J Am Geriatr Soc 2009; 57(9):1713-1714

26.

Sil A, Mondal S, Bhanja DB, Datta M, Mukherjee GS, Chakraborty S. Pruritic genital nodules. Pediatr Neonatol 2020; 61(2):243-244

27.

Heukelbach J, Feldmeier H. Scabies. Lancet 2006; 367(9524):1767-1774

28.

Aydıngöz İE, Mansur AT. Canine scabies in humans: a case report and review of the literature. Dermatology 2011; 223(2):104-106

29.

Currie BJ, McCarthy JS. Permethrin and ivermectin for scabies. N Engl J Med 2010; 362(8):717-725

30.

Diab HM. Scabies incognito: diagnostic value of dermoscopy-guided microscopic examination. J Egypt Women Dermatol Soc 2017; 14(1):56-60

31.

Sunderkötter C, Feldmeier H, Fölster-Holst R, Geisel B, Klinke-Rehbein S, Nast A, et al. S1 guidelines on the diagnosis and treatment of scabies: short version. J Dtsch Dermatol Ges 2016; 14(11):1155-1167

32.

Park SY, Roh JY, Lee JY, Kim DW, Yoon TJ, Sim WY, et al. A clinical and epidemiological study of scabies in Korea: a multicenter prospective study. Korean J Dermatol 2014; 52(7):457-464.

33.

Tsoi SK, Lake SJ, Thean LJ, Matthews A, Sokana O, Kama M, et al. Estimation of scabies prevalence using simplified criteria and mapping procedures in three Pacific and southeast Asian countries. BMC Public Health 2021; 21(1):2060

34.

Walker SL, Collinson S, Timothy J, Zayzay SK, Kollie KK, Candy N, et al. A community-based validation of the International Alliance for the Control of Scabies Consensus Criteria by expert and non-expert examiners in Liberia. PLoS Negl Trop Dis 2020; 14(10):0008717

35.

Leung V, Miller M. Detection of scabies: a systematic review of diagnostic methods. Can J Infect Dis Med Microbiol 2011; 22(4):143-146

36.

Woodley D, Saurat JH. The Burrow Ink test and the scabies mite. J Am Acad Dermatol 1981; 4(6):715-722

37.

Muller G, Jacobs PH, Moore NE. Scraping for human scabies: a better method for positive preparations. Arch Dermatol 1973; 107(1):70

38.

Walter B, Heukelbach J, Fengler G, Worth C, Hengge U, Feldmeier H. Comparison of dermoscopy, skin scraping, and the adhesive tape test for the diagnosis of scabies in a resource-poor setting. Arch Dermatol 2011; 147(4):468-473

39.

Cho BK, Lee WK. Mite and tick related dermatoses. Seoul: Seoheung. 2004.

40.

Lacarrubba F, Musumeci ML, Caltabiano R, Impallomeni R, West DP, Micali G. High-magnification videodermatoscopy: a new noninvasive diagnostic tool for scabies in children. Pediatr Dermatol 2001; 18(5):439-441

41.

Argenziano G, Fabbrocini G, Delfino M. Epiluminescence microscopy: a new approach to in vivo detection of Sarcoptes scabiei. Arch Dermatol 1997; 133(6):751-753

42.

Dupuy A, Dehen L, Bourrat E, Lacroix C, Benderdouche M, Dubertret L, et al. Accuracy of standard dermoscopy for diagnosing scabies. J Am Acad Dermatol 2007; 56(1):53-62

43.

Park JH, Kim CW, Kim SS. The diagnostic accuracy of dermoscopy for scabies. Ann Dermatol 2012; 24(2):194-199

44.

Li FZ, Chen S. Diagnostic accuracy of dermoscopy for scabies. Korean J Parasitol 2020; 58(6):669-674

45.

Shoukat Q, Rizvi A, Wahood W, Coetzee S, Wrench A. Sight the mite: a meta-analysis on the diagnosis of scabies. Cureus 2023; 15(1):34390

46.

Ueda T, Katsura Y, Sasaki A, Minagawa D, Amoh Y, Shirai K. Gray-edged line sign of scabies burrow. J Dermatol 2021; 48(2):190-198

47.

Arora P, Rudnicka L, Sar-Pomian M, Wollina U, Jafferany M, Lotti T, et al. Scabies: a comprehensive review and current perspectives. Dermatol Ther 2020; 33(4):13746

48.

Lacarrubba F, Verzì AE, Micali G. Detailed analysis of in vivo reflectance confocal microscopy for Sarcoptes scabiei hominis. Am J Med Sci 2015; 350(5):414

49.

Cinotti E, Labeille B, Cambazard F, Biron AC, Chol C, Leclerq A, et al. Videodermoscopy compared to reflectance confocal microscopy for the diagnosis of scabies. J Eur Acad Dermatol Venereol 2016; 30(9):1573-1577

50.

Banzhaf CA, Themstrup L, Ring HC, Welzel J, Mogensen M, Jemec GBE. In vivo imaging of Sarcoptes scabiei infestation using optical coherence tomography. Case Rep Dermatol 2013; 5(2):156-162

51.

Head ES, Macdonald EM, Ewert A, Apisarnthanarax P. Sarcoptes scabiei in histopathologic sections of skin in human scabies. Arch Dermatol 1990; 126(11):1475-1477

52.

Arlian LG, Feldmeier H, Morgan MS. The potential for a blood test for scabies. PLoS Negl Trop Dis 2015; 9(10):0004188

53.

David N, Rajamanoharan S, Tang A. Are sexually transmitted infections associated with scabies?. Int J STD AIDS 2002; 13(3):168-170

54.

Bae M, Kim JY, Jung J, Cha HH, Jeon NY, Lee HJ, et al. Diagnostic value of the molecular detection of Sarcoptes scabiei from a skin scraping in patients with suspected scabies. PLoS Negl Trop Dis 2020; 14(4):0008229

55.

Wong SSY, Poon RWS, Chau S, Wong SCY, To KKW, Cheng VCC, et al. Development of conventional and real-time quantitative PCR assays for diagnosis and monitoring of scabies. J Clin Microbiol 2015; 53(7):2095-2102

56.

Hahm JE, Kim CW, Kim SS. The efficacy of a nested polymerase chain reaction in detecting the cytochrome c oxidase subunit 1 gene of Sarcoptes scabiei var. hominis for diagnosing scabies. Br J Dermatol 2018; 179(4):889-895